Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study

Immunotherapy and target therapy have revolutionized treatment of stage III/IV melanoma. Both treatments show a favorable toxicity profile even if cutaneous adverse events (AEs) are frequent (30%–40% of cases). This is a retrospective single center cohort study that included patients with stage IV o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gullo, Giulia, Rubatto, Marco, Fava, Paolo, Brizio, Matteo, Tonella, Luca, Ribero, Simone, Medri, Matelda, Avallone, Gianluca, Mastorino, Luca, Fierro, Maria Teresa, Stanganelli, Ignazio, Quaglino, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287008/
https://www.ncbi.nlm.nih.gov/pubmed/35384181
http://dx.doi.org/10.1111/dth.15492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287008/
https://www.ncbi.nlm.nih.gov/pubmed/35384181
http://dx.doi.org/10.1111/dth.15492

Ejemplares similares